Search research articles
Contact Us
Filters
Showing results (91-100 of 151) with videos related to
Page
of 16
Sort By:
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
October 5, 2012
Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64
Parijat Bhatnagar, Zheng Li, Yoonsu Choi, et al.
Blood
|
October 28, 2004
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1
Laurence J N Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, et al.
Journal of Pediatric Hematology/Oncology
|
September 1, 2017
Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults
Ossama M Maher, Jorge G Silva, Winston W Huh, et al.
Cytotherapy
|
May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma
L J N Cooper, L Ausubel, M Gutierrez, et al.
Blood
|
October 24, 2002
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
Laurence J N Cooper, Max S Topp, Lisa Marie Serrano, et al.
Cancer Immunology Research
|
February 26, 2015
Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
Ivan Liadi, Harjeet Singh, Gabrielle Romain, et al.
Oncotarget
|
June 21, 2016
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
Chiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, et al.
Scientific Reports
|
June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
Mireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Cancer Research
|
May 12, 2011
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Cancer Research
|
April 17, 2008
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system
Harjeet Singh, Pallavi R Manuri, Simon Olivares, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 151) with videos related to
Sort By:
Page
of 16
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
October 5, 2012
Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64
Parijat Bhatnagar, Zheng Li, Yoonsu Choi, et al.
Blood
|
October 28, 2004
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1
Laurence J N Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, et al.
Journal of Pediatric Hematology/Oncology
|
September 1, 2017
Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults
Ossama M Maher, Jorge G Silva, Winston W Huh, et al.
Cytotherapy
|
May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma
L J N Cooper, L Ausubel, M Gutierrez, et al.
Blood
|
October 24, 2002
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
Laurence J N Cooper, Max S Topp, Lisa Marie Serrano, et al.
Cancer Immunology Research
|
February 26, 2015
Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
Ivan Liadi, Harjeet Singh, Gabrielle Romain, et al.
Oncotarget
|
June 21, 2016
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
Chiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, et al.
Scientific Reports
|
June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
Mireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Cancer Research
|
May 12, 2011
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.
Cancer Research
|
April 17, 2008
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system
Harjeet Singh, Pallavi R Manuri, Simon Olivares, et al.
Page
of 16